ZA881962B - 19,11beta-bridged steriods,their manufacture and pharmaceutical preparations containing them - Google Patents
19,11beta-bridged steriods,their manufacture and pharmaceutical preparations containing themInfo
- Publication number
- ZA881962B ZA881962B ZA881962A ZA881962A ZA881962B ZA 881962 B ZA881962 B ZA 881962B ZA 881962 A ZA881962 A ZA 881962A ZA 881962 A ZA881962 A ZA 881962A ZA 881962 B ZA881962 B ZA 881962B
- Authority
- ZA
- South Africa
- Prior art keywords
- radical
- hydrogen atom
- alkyl radical
- image
- bond
- Prior art date
Links
- 238000004519 manufacturing process Methods 0.000 title 1
- 239000000825 pharmaceutical preparation Substances 0.000 title 1
- -1 C1-C4-alkyl radical Chemical class 0.000 abstract 8
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 6
- 125000004432 carbon atom Chemical group C* 0.000 abstract 2
- 125000000816 ethylene group Chemical group [H]C([H])([*:1])C([H])([H])[*:2] 0.000 abstract 2
- 125000001570 methylene group Chemical group [H]C([H])([*:1])[*:2] 0.000 abstract 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 150000007513 acids Chemical class 0.000 abstract 1
- 125000002837 carbocyclic group Chemical group 0.000 abstract 1
- 229910052801 chlorine Inorganic materials 0.000 abstract 1
- 125000001309 chloro group Chemical group Cl* 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- QUPDWYMUPZLYJZ-UHFFFAOYSA-N ethyl Chemical compound C[CH2] QUPDWYMUPZLYJZ-UHFFFAOYSA-N 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 1
- 125000000325 methylidene group Chemical group [H]C([H])=* 0.000 abstract 1
- 125000004430 oxygen atom Chemical group O* 0.000 abstract 1
- 230000000144 pharmacologic effect Effects 0.000 abstract 1
- 150000003254 radicals Chemical class 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 150000003431 steroids Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
- C07J71/0036—Nitrogen-containing hetero ring
- C07J71/0057—Nitrogen and oxygen
- C07J71/0063—Nitrogen and oxygen at position 2(3)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
- A61P5/44—Glucocorticosteroids; Drugs increasing or potentiating the activity of glucocorticosteroids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
- C07J21/005—Ketals
- C07J21/006—Ketals at position 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
- C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
- C07J41/0038—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 with an androstane skeleton, including 18- or 19-substituted derivatives, 18-nor derivatives and also derivatives where position 17-beta is substituted by a carbon atom not directly bonded to a further carbon atom and not being part of an amide group
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
- C07J53/002—Carbocyclic rings fused
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
- C07J71/0005—Oxygen-containing hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
- C07J71/0036—Nitrogen-containing hetero ring
- C07J71/0042—Nitrogen only
- C07J71/0047—Nitrogen only at position 2(3)
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Endocrinology (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Diabetes (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- External Artificial Organs (AREA)
- Separation By Low-Temperature Treatments (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19873708942 DE3708942A1 (de) | 1987-03-18 | 1987-03-18 | 19,11ss-ueberbrueckte steroide, deren herstellung und diese enthaltende pharmazeutische praeparate |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA881962B true ZA881962B (en) | 1988-09-08 |
Family
ID=6323462
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA881962A ZA881962B (en) | 1987-03-18 | 1988-03-18 | 19,11beta-bridged steriods,their manufacture and pharmaceutical preparations containing them |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US5095129A (OSRAM) |
| EP (1) | EP0283428B1 (OSRAM) |
| JP (1) | JP2588267B2 (OSRAM) |
| CN (3) | CN1033033C (OSRAM) |
| AT (1) | ATE69055T1 (OSRAM) |
| AU (1) | AU628015B2 (OSRAM) |
| CA (1) | CA1326015C (OSRAM) |
| DD (1) | DD273262A5 (OSRAM) |
| DE (2) | DE3708942A1 (OSRAM) |
| ES (1) | ES2040373T3 (OSRAM) |
| FI (1) | FI101883B (OSRAM) |
| GR (1) | GR3003362T3 (OSRAM) |
| HU (2) | HU206368B (OSRAM) |
| IE (1) | IE62480B1 (OSRAM) |
| IL (1) | IL85773A (OSRAM) |
| NZ (1) | NZ223924A (OSRAM) |
| PT (1) | PT87007B (OSRAM) |
| WO (1) | WO1988007051A1 (OSRAM) |
| ZA (1) | ZA881962B (OSRAM) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0360369A1 (de) * | 1988-09-20 | 1990-03-28 | Schering Aktiengesellschaft | 11Beta-phenyl-14betaH-steroide |
Families Citing this family (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5446178A (en) * | 1987-03-18 | 1995-08-29 | Schering Aktiengesellschaft | Process for preparing 19,11β-bridged steroids |
| DE3917274A1 (de) * | 1989-05-24 | 1990-11-29 | Schering Ag | 9(alpha)-hydroxy-19, 11(beta)-ueberbrueckte steroide, deren herstellung und diese enthaltende pharmazeutische praeparate |
| DE3921059A1 (de) * | 1989-06-23 | 1991-01-10 | Schering Ag | 11(beta)-aryl-4-estrene, verfahren zu ihrer herstellung sowie deren verwendung als arzneimittel |
| DD289541A5 (de) * | 1989-08-04 | 1991-05-02 | ��@�K@�������������@�K@��������������@��������k�� | Verfahren zur herstellung von 11beta-aryl-16 alpha, 17 alph-cyclohexanoestra-4,9-dienen |
| DE4038128A1 (de) * | 1990-11-27 | 1992-06-04 | Schering Ag | 8-en-19, 11(beta)-ueberbrueckte steroide, deren herstellung und diese enthaltende pharmazeutische praeparate |
| US5439913A (en) * | 1992-05-12 | 1995-08-08 | Schering Aktiengesellschaft | Contraception method using competitive progesterone antagonists and novel compounds useful therein |
| DE4235220A1 (de) * | 1992-10-13 | 1994-06-16 | Schering Ag | Gestagen wirksame 19,11ß-überbrückte 4-Estrene |
| DE4413184A1 (de) * | 1994-04-12 | 1995-10-19 | Schering Ag | 10,11-C¶3¶-überbrückte Steroide |
| DE4413185A1 (de) * | 1994-04-12 | 1995-10-19 | Schering Ag | 11beta,19-überbrückte 13alpha-Alkylsteroide |
| DE4417880A1 (de) * | 1994-05-18 | 1995-11-23 | Schering Ag | 19,11beta-Überbrückte 18-Nor-Steroide, Verfahren zu ihrer Herstellung, diese Steroide enthaltende Arzneimittel sowie deren Verwendung zur Herstellung von Arzneimitteln |
| US5780220A (en) * | 1994-05-19 | 1998-07-14 | Trustees Of The University Of Pennsylvania | Methods and compositions for inhibiting HIV replication |
| US5639598A (en) * | 1994-05-19 | 1997-06-17 | The Trustees Of The University Of Pennsylvania | Method and kit for identification of antiviral agents capable of abrogating HIV Vpr-Rip-1 binding interactions |
| DE4424222C1 (de) * | 1994-07-09 | 1995-09-14 | Metallgesellschaft Ag | Gelöstes Methyllithium enthaltendes Synthesemittel sowie Verfahren zu deren Herstellung |
| DE4434488A1 (de) * | 1994-09-14 | 1996-03-21 | Schering Ag | Steroidester und -amide, Verfahren zu ihrer Herstellung und ihre pharmazeutische Verwendung |
| US5521166A (en) * | 1994-12-19 | 1996-05-28 | Ortho Pharmaceitical Corporation | Antiprogestin cyclophasic hormonal regimen |
| ZA9510926B (en) | 1994-12-23 | 1996-07-03 | Schering Ag | Compounds with progesterone-antagonistic and antiestrogenic action to be used together for female contraception |
| IL118974A (en) * | 1995-08-17 | 2001-09-13 | Akzo Nobel Nv | History 11 - (Transformed Phenyl) - Astra - 4, 9 - Diane, their preparation and pharmaceutical preparations containing them |
| DE19652408C2 (de) * | 1996-12-06 | 2002-04-18 | Schering Ag | Steroidester, Verfahren zu ihrer Herstellung und ihre Verwendung zur Herstellung von Arzneimitteln |
| US6090798A (en) * | 1997-12-19 | 2000-07-18 | Alcon Laboratories, Inc. | Treatment of GLC1A glaucoma with glucocorticoid antagonists |
| GB0000313D0 (en) | 2000-01-10 | 2000-03-01 | Astrazeneca Uk Ltd | Formulation |
| PT3263112T (pt) | 2006-10-24 | 2020-08-25 | Allergan Pharmaceuticals Int Ltd | Composições e métodos para supressão de proliferações do endométrio |
| TWI539953B (zh) | 2008-04-28 | 2016-07-01 | 瑞波若斯治療學公司 | 用於治療乳癌之組成物和方法 |
| CN107260745A (zh) | 2010-03-22 | 2017-10-20 | 利普生物药剂公司 | 用于抗孕酮的非毒性递送的组合物和方法 |
| ES2762243T3 (es) | 2010-05-26 | 2020-05-22 | Corcept Therapeutics Inc | Tratamiento de distrofia muscular |
| CN103555806B (zh) * | 2013-11-16 | 2015-05-13 | 江南大学 | 一种高效利用亚麻刺盘孢霉合成7α-羟基-雄甾烯酮的方法 |
| CN107530435A (zh) | 2015-03-02 | 2018-01-02 | 科赛普特治疗学股份有限公司 | 使用糖皮质激素受体拮抗剂和生长抑素治疗acth分泌型肿瘤 |
| MX383353B (es) | 2015-03-30 | 2025-03-13 | Corcept Therapeutics Inc | Uso de antagonistas de receptores de glucocorticoides en combinacion con glucocorticoides para tratar la insuficiencia adrenal. |
| MX383318B (es) | 2015-08-13 | 2025-03-13 | Corcept Therapeutics Inc | Metodo para diagnosticar de manera diferencial el sindrome de cushing dependiente de la corticotropina. |
| EP3405101B1 (en) | 2016-01-19 | 2020-12-23 | Corcept Therapeutics, Inc. | Differential diagnosis of ectopic cushing's syndrome |
| MX2019011543A (es) | 2017-03-31 | 2019-12-16 | Corcept Therapeutics Inc | Moduladores del receptor de glucocorticoides para el tratamiento de cancer cervical. |
| MX393313B (es) | 2017-06-20 | 2025-03-24 | Corcept Therapeutics Inc | Metodos de tratamiento de tumores neuroepiteliales usando moduladores selectivos del receptor de glucocorticoide. |
| AU2021400069A1 (en) | 2020-12-18 | 2023-07-06 | Instil Bio (Uk) Limited | Processing of tumor infiltrating lymphocytes |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ZA8231B (en) * | 1981-01-09 | 1982-11-24 | Roussel Uclaf | New 11 -substituted steroid derivatives, their preparation, their use as medicaments, the compositions containing them and the new intermediates thus obtained |
| FR2522328B1 (fr) * | 1982-03-01 | 1986-02-14 | Roussel Uclaf | Nouveaux produits derives de la structure 3-ceto 4,9 19-nor steroides, leur procede de preparation et leur application comme medicaments |
| FR2576025B1 (fr) * | 1985-01-14 | 1987-01-23 | Roussel Uclaf | Nouveaux steroides substitues en position 10, leur procede et les intermediaires de preparation, leur application comme medicaments, les compositions pharmaceutiques les contenant |
-
1987
- 1987-03-18 DE DE19873708942 patent/DE3708942A1/de not_active Withdrawn
-
1988
- 1988-03-11 EP EP88730061A patent/EP0283428B1/de not_active Expired - Lifetime
- 1988-03-11 JP JP63502319A patent/JP2588267B2/ja not_active Expired - Fee Related
- 1988-03-11 ES ES198888730061T patent/ES2040373T3/es not_active Expired - Lifetime
- 1988-03-11 DE DE88730061T patent/DE3865863D1/de not_active Expired - Lifetime
- 1988-03-11 AU AU14209/88A patent/AU628015B2/en not_active Ceased
- 1988-03-11 HU HU911518A patent/HU206368B/hu not_active IP Right Cessation
- 1988-03-11 AT AT88730061T patent/ATE69055T1/de not_active IP Right Cessation
- 1988-03-11 WO PCT/DE1988/000150 patent/WO1988007051A1/de not_active Ceased
- 1988-03-17 IL IL8577388A patent/IL85773A/en not_active IP Right Cessation
- 1988-03-17 DD DD88313750A patent/DD273262A5/de not_active IP Right Cessation
- 1988-03-17 CA CA000561771A patent/CA1326015C/en not_active Expired - Fee Related
- 1988-03-17 NZ NZ223924A patent/NZ223924A/en unknown
- 1988-03-18 ZA ZA881962A patent/ZA881962B/xx unknown
- 1988-03-18 IE IE79388A patent/IE62480B1/en not_active IP Right Cessation
- 1988-03-18 CN CN88102162A patent/CN1033033C/zh not_active Expired - Fee Related
- 1988-03-18 PT PT87007A patent/PT87007B/pt not_active IP Right Cessation
- 1988-12-09 US US07/283,632 patent/US5095129A/en not_active Expired - Fee Related
-
1989
- 1989-09-15 FI FI894364A patent/FI101883B/fi not_active IP Right Cessation
-
1991
- 1991-12-17 GR GR91401682T patent/GR3003362T3/el unknown
-
1994
- 1994-07-11 HU HU94P/P00010P patent/HU210532A9/hu unknown
-
1996
- 1996-01-17 CN CN96100917A patent/CN1057770C/zh not_active Expired - Fee Related
- 1996-02-01 CN CN96102566A patent/CN1080267C/zh not_active Expired - Fee Related
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0360369A1 (de) * | 1988-09-20 | 1990-03-28 | Schering Aktiengesellschaft | 11Beta-phenyl-14betaH-steroide |
| WO1990003385A1 (de) * | 1988-09-20 | 1990-04-05 | Schering Aktiengesellschaft Berlin Und Bergkamen | 11β-PHENYL-14βH-STEROIDE |
Also Published As
| Publication number | Publication date |
|---|---|
| NZ223924A (en) | 1991-12-23 |
| HU210532A9 (en) | 1995-04-28 |
| EP0283428A1 (de) | 1988-09-21 |
| DE3865863D1 (OSRAM) | 1991-12-05 |
| PT87007B (pt) | 1992-06-30 |
| JPH02503194A (ja) | 1990-10-04 |
| EP0283428B1 (de) | 1991-10-30 |
| ES2040373T3 (es) | 1993-10-16 |
| IE880793L (en) | 1988-09-18 |
| IE62480B1 (en) | 1995-02-08 |
| CN1033033C (zh) | 1996-10-16 |
| IL85773A (en) | 1994-01-01 |
| CN1135488A (zh) | 1996-11-13 |
| PT87007A (pt) | 1988-04-01 |
| HU206368B (en) | 1992-10-28 |
| CN88102162A (zh) | 1988-11-23 |
| WO1988007051A1 (fr) | 1988-09-22 |
| CA1326015C (en) | 1994-01-11 |
| FI894364A0 (fi) | 1989-09-15 |
| GR3003362T3 (en) | 1993-02-17 |
| HU911518D0 (en) | 1991-11-28 |
| CN1080267C (zh) | 2002-03-06 |
| IL85773A0 (en) | 1988-09-30 |
| ATE69055T1 (de) | 1991-11-15 |
| DD273262A5 (de) | 1989-11-08 |
| CN1141926A (zh) | 1997-02-05 |
| JP2588267B2 (ja) | 1997-03-05 |
| AU628015B2 (en) | 1992-09-10 |
| US5095129A (en) | 1992-03-10 |
| CN1057770C (zh) | 2000-10-25 |
| AU1420988A (en) | 1988-10-10 |
| FI101883B1 (fi) | 1998-09-15 |
| FI101883B (fi) | 1998-09-15 |
| DE3708942A1 (de) | 1988-09-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA881962B (en) | 19,11beta-bridged steriods,their manufacture and pharmaceutical preparations containing them | |
| DE69021176D1 (de) | Polypeptid und Verfahren zu dessen Herstellung. | |
| IE792028L (en) | Pyrroloazetidinones | |
| HK1005881A1 (en) | Pregna-1,4-diene-3,20-dione-16-17-acetal-21 esters | |
| NO912347D0 (no) | Fremgangsmaate for fremstilling av nye polypeptider. | |
| GB1447599A (en) | Derivatives of alpha-methyldopa | |
| AU1178588A (en) | New 19-norsteroids substituted at the 7-position, their preparation, their application as drugs and the pharmaceutical compositions containing them | |
| HUP9702509A2 (hu) | Kondenzált heterociklusos vegyületek aminocsoportjukon szubsztituált származékai, eljárás előállításukra, alkalmazásuk és az ezeket tartalmazó gyógyszerkészítmények | |
| DK96783D0 (da) | Fremgangsmade til fremstilling af 4''-epierythromycin a eller derivater deraf | |
| TW249804B (OSRAM) | ||
| ES8703884A1 (es) | Un procedimiento para preparar antibioticos de cefalosporina. | |
| HUT50142A (en) | Process for producing allyl-mercapto-acetyl-sidnonimine derivatives and pharmaceutical compositions containing them | |
| ES8205224A1 (es) | Un procedimiento para la preparacion de acidos 1-carbadetiapen-2-em-3-carboxilios 6-1-y 2-sustituidos. | |
| ES8304571A1 (es) | "procedimiento para la preparacion de nuevas 1,4,9,10-tetrahidro-pirazolo (4,3-e)pirido (3,2-b) (1,4)diazepin-10-onas". | |
| NO960425D0 (no) | 15,15-dialkyl-substituerte derivater av östradiol | |
| EP0312773A3 (en) | Substituted 3-aminosydnonimines, process for their preparation and their use | |
| EP0367036A3 (en) | Substituted 3-aminosydnonimines, process for their preparation and their use | |
| FI951834L (fi) | 19,11 -sillan käsittäviä steroideja | |
| ATE130309T1 (de) | 14alpha,16alpha-ethano- und 14alpha,16alpha- ethenoestratriene. | |
| FI921238A7 (fi) | Välituotteina käytettävät N'-alkoksi- tai N'-aralkyylioksi-N6-syano-griseoliinihapon johdannaiset |